GSK plc Depreciation And Amortization for the year ending December 31, 2024: USD 3.19 B

GSK plc Depreciation And Amortization is USD 3.19 B for the year ending December 31, 2024, a 9.35% change year over year. Depreciation and amortization are expense that reduces the value of tangible and intangible assets over their useful lives for tax and reporting purposes.
  • GSK plc Depreciation And Amortization for the year ending December 31, 2023 was USD 2.92 B, a 5.09% change year over year.
  • GSK plc Depreciation And Amortization for the year ending December 31, 2022 was USD 2.78 B, a -18.69% change year over year.
  • GSK plc Depreciation And Amortization for the year ending December 31, 2021 was USD 3.42 B, a 300.82% change year over year.
  • GSK plc Depreciation And Amortization for the year ending December 31, 2020 was USD 852.14 M, a -78.53% change year over year.
Key Data
Date Depreciation And Amortization Dividends Paid Common Stock Issued Common Stock Repurchased